Operating profit before deduction of amortization: hcwbiologics.com (HCWB)
HCW Biologics Inc. (HCWB) minimizes research risks by developing therapies to combat oncology and age-related pathologies. Commercial revenue is currently absent as the drugs are undergoing clinical trials. Patent protection of protein structures shields the niche from industry behemoths. Absolute operating income before depreciation and amortization demonstrates the internal resilience of the business, where the value of 0.00 corresponds to the current metric.
HCW Biologics (HCWB) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio HCW Biologics Inc.|HCWB - Long-Term Debt to Capital|Current Liabilities to Capital HCW Biologics, Inc.|HCWB - Company Aggregate Debts|Debt to Net Assets Ratio HCW Biologics|HCWB - Company Long-Term Debts|Company Current Liabilities HCW Biologics|Quick Liquidity Indicator hcwbiologics.com
- earnings and multiples data:
HCWB - Net Income|Expected Net Income HCW Biologics Inc.|HCWB - P/E Multiple|Future Price to Earnings HCW Biologics, Inc.|HCWB - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio HCW Biologics|HCWB - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months HCW Biologics|HCWB - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months hcwbiologics.com|HCWB - Earnings per share growth in current year|Expected net earnings per share growth next year HCW Biologics Inc.
Summary company analytics:HCW Biologics Inc.
The implementation of emission filtration systems and the transition of HCW Biologics Inc. (HCWB) to renewable energy require significant operating expenses that directly impact current liquidity. Analyzing the EBITDA_Co chart, an investor can see the net cash flow from core operations excluding depreciation and interest, which allows for an objective assessment of the real cost of capital and prevents overpaying for the asset.
Who HCW Biologics Inc. competes with
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BioCryst Pharmaceuticals Inc - Operating profit EBITDA|Income before deduction of interest, taxes and amortization VERA (Vera Corp)|DNTH: Operating profit EBITDA|Operating profit before deduction of amortization pharvaris.com|Operating profit before deduction of amortization ABCL|Operating profit before deduction of amortization Tourmaline Bio Inc (TRML)|Operating profit before deduction of amortization PGEN (Intrexon)|PHAR (Pharming Corp) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NKTR (Nektar Therapeutics)|upstreambio.com - Profit before payment of interest, taxes and amortization|Zenas Biopharma - Operating profit EBITDA|Operating income before deduction of amortization Immunome Inc IMNM|Gossamer Corp (GOSS) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization KalVista Corp (KALV)|Profit before payment of interest, taxes and amortization Septerna Inc|Profit before payment of interest, taxes and amortization PVLA|Profit before payment of interest, taxes and amortization Savara (SVRA)|RIGL - Profit before interest, taxes and amortization|Operating profit EBITDA ANAB (AnaptysBio Corp)|Operating profit before depreciation charges Astria Corp|enGene Holdings Inc. - Operating profit EBITDA|Operating income before deduction of amortization RAPT Therapeutics Inc. RAPT|JBIO: Operating profit EBITDA|Operating profit before deduction of amortization Aclaris Therapeutics Inc.|Profit before payment of interest, taxes and amortization Kyverna|Tiziana Life Sciences, Ltd. (TLSA) - Operating income before deduction of amortization|Operating profit before deduction of amortization CABA (Cabaletta Bio, Inc.)|VTYX (ventyxbio.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA THTX (Theratechnologies)|Operating income before deduction of amortization Avalo Therapeutics, Inc. (AVTX)|ELDN - Profit before payment of interest, taxes and amortization|AGEN (Agenus, Inc) - Operating profit before amortization|CLYM: Operating profit EBITDA|Operating profit before deduction of amortization Zura Bio Ltd|Operating profit before deduction of amortization ATYR|Adagene Corp (ADAG) - Operating income before deduction of amortization|Operating profit EBITDA IMA|STTK (shattucklabs.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA EQ (Equillium)|CNTB - Operating profit before deduction of amortization|IMUX: Operating profit before deduction of amortization|Atara Biotherapeutics (ATRA) - Operating profit before deduction of amortization|IFRX: Operating profit EBITDA|XFOR (X4 Pharmaceuticals, Inc) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Adicet Bio Inc.|Celularity Corp - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA INMB|BRNS (Barinthus Biotherapeutics PLC) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA KZR (Kezar Life Sciences, Inc)|Operating profit EBITDA SAB Biotherapeutics Inc SABS|AKTX - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization ENLV (Enlivex Therapeutics)|q32bio.com (QTTB) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization GeoVax Labs|EDSA (Edesa) - Operating profit EBITDA|Operating profit EBITDA iBio Corporation|Operating profit before deduction of amortization CARM (Carisma Therapeutics)|XTLB (xtlbio.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA BOLT (Bolt Biotherapeutics, Inc.)|Operating income before deduction of amortization Aptevo Therapeutics, Inc. (APVO)|AIM - Profit before payment of interest, taxes and amortization|Aditxt (ADTX) - Operating profit before deduction of amortization|GRI Bio, Inc. (GRI) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization xortx.com|Operating profit before deduction of amortization HIND|Operating profit EBITDA Revelation Biosciences Inc|Profit before payment of interest, taxes and amortization Indaptus (INDP)|BiondVax Pharmaceuticals - Operating profit before amortization|Operating profit EBITDA CALI (CalciMedica)|Affimed NV (AFMD) - Profit before interest, taxes and amortization|Allakos Therapeutics - Operating profit EBITDA|Income before deduction of interest, taxes and amortization HOOK (HOOKIPA Pharma Inc.)|IGMS: Operating profit EBITDA|Operating profit before deduction of amortization iTeos Pharma|Operating profit before deduction of amortization OCEA|Operating profit before deduction of amortization tcbiopharm.com (TCBP)|Operating profit before deduction of amortization THRD (Third Harmonic Bio, Inc.)
